Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment

DOI: 10.1080/2162402X.2018.1450712

Keywords: Erdheim-Chester disease, anakinra, BRAF mutation, NRAS mutation, vemurafenib

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text